Match vs 1 year's supply of entecavir Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
| Author List |
|---|
| Andrew Hill |
| Dzintars Gotham |
| Graham Cooke et al. |
Abstract
As NGOs consider the opportunity to scale up treatment of hepatitis B in low- to middle-income countries, it is of value to the broader community to understand the potential minimum cost of large-scale treatment for CHB using standard-of-care treatments.
Published
Article Category
Hepatitis B (HBV)
Article Type
Original research
Posted Date
01-04-2015
Tables & Figures
Back to top